ADLAI NORTYE ANNOUNCES FIRST PATIENT DOSED IN INTERMITTENT WEEKLY DOSING ARM OF GLOBAL PHASE 1 TRIAL OF PAN-RAS(ON) INHIBITOR AN9025

Reuters · 1d ago

Please log in to view news